KLA Corporation (KLA) — Form 10-Q Summary
Period: Fiscal third quarter and nine months ended March 31, 2022; filed April 29, 2022. The request metadata says “2021 Q3,” but the filing covers Q3 FY2022. Financial statements are unaudited.
Business context and reporting period
KLA supplies inspection, metrology, analytics and related services for semiconductor manufacturing, alongside specialty semiconductor, PCB, display and component inspection products. Demand strengthened, particularly for semiconductor inspection and metrology, amid investment in advanced technologies. Results remain exposed to semiconductor capital-spending cycles, customer concentration and supply-chain constraints.
Key financial metrics
| Metric | Three months ended Mar. 31, 2022 | Year-over-year change | Nine months ended Mar. 31, 2022 | Year-over-year change |
|---|---|---|---|---|
| Revenue | $2.289 billion | +27% | $6.725 billion | +35% |
| Gross margin | 61.0% | 60.7% prior year | 61.1% | 59.9% prior year |
| Net income attributable to KLA | $730.6 million | $567.5 million prior year | $2.516 billion | $1.445 billion prior year |
| Diluted EPS | $4.83 | $3.66 prior year | $16.52 | $9.28 prior year |
| Operating cash flow | Not stated for the quarter | — | $2.493 billion | $1.719 billion prior year |
Q3 product revenue rose 31% to $1.801 billion and service revenue rose 14% to $488.0 million. For nine months, product revenue increased 42% and service revenue 13%. SPC revenue increased 31% in Q3 and 40% year to date; PCB, Display and Component Inspection revenue declined 6% in Q3 but rose 3% year to date. China and Taiwan each represented 22% or more of Q3 revenue, while Korea accounted for 21%.
Cash, cash equivalents and marketable securities totaled $2.578 billion at March 31, 2022, versus $2.495 billion at June 30, 2021. Working capital was $3.75 billion, up from $3.59 billion. Debt had a $3.700 billion carrying value ($3.725 billion principal), including $275 million drawn on a $1.0 billion revolving facility; the company reported compliance with debt covenants. Nine-month investing cash outflow was $851.1 million and financing cash outflow was $1.653 billion. Financing uses included $1.394 billion of share repurchases and $480.9 million of dividends.
Material changes versus prior comparable periods
- Growth was led by SPC and semiconductor product demand; higher revenue volume and product mix helped lift year-to-date gross margin by 1.2 percentage points.
- Higher shipping and other service/manufacturing costs partly offset margin gains. R&D and SG&A increased year to date by 18% and 16%, respectively, mainly reflecting employee-related costs and expanded activity.
- Nine-month effective tax rate was 0.9%, versus 12.6% a year earlier. A non-recurring $394.5 million tax benefit from transferring certain IP rights to a Singapore subsidiary was partly offset by a $163.7 million deferred tax expense following a change in Israeli tax law.
- Inventory increased to $1.982 billion from $1.575 billion at June 30, 2021, and accounts receivable rose to $1.619 billion from $1.305 billion. Management attributed working-capital cash demands partly to growth and extended supply lead times.
Outlook, risks and unusual items
- The filing gives no specific numerical revenue or earnings guidance. Management said existing cash, operating cash generation and available revolving credit should meet liquidity needs for at least the next 12 months.
- Remaining performance obligations were $10.55 billion; management expected approximately 30%–45% to be recognized as revenue beyond the next 12 months. Timing is subject to supply constraints, customer schedule changes and demand.
- Management described extended supplier lead times and component shortages, with increased purchase commitments to secure supply. Commitments for purchases, primarily due within 12 months, were estimated at $3.4 billion. COVID-19-related restrictions in China could further delay deliveries and installations.
- Customer concentration is material: two customers represented approximately 17% and 16% of Q3 revenue. Export controls and licensing restrictions affecting certain China-based entities could constrain sales; management said restrictions had not significantly affected operations to date.
- KLA acquired ECI Technology for $431.5 million net of cash acquired; its results contributed $8.1 million of revenue and a $0.4 million net loss after acquisition. The company also classified Orbograph, a non-core business, as held for sale and expected a sale within 12 months; no impairment was recorded.
- Israeli tax assessments remain disputed, including tax decrees relating to 2012–2014 and 2015–2016 and an assessment covering 2017–2018. KLA said recorded unrecognized tax benefits were sufficient. A related criminal investigation was closed in March 2022 for lack of evidence.
- Other disclosed exposures include market interest-rate and investment-price risk, foreign exchange, litigation and potential product indemnification claims. The company reported no material off-balance-sheet arrangements and effective disclosure controls.
Most important facts for investors to verify
- Whether reported growth and the $10.55 billion performance-obligation balance convert to revenue on expected schedules despite supply constraints and customer rescheduling.
- Whether inventory growth, supplier commitments and component availability create higher obsolescence, delivery or margin risk.
- The recurring earnings and cash-tax effects after the one-time IP-transfer tax benefit and the Israeli tax-law charge; track outcomes of the ongoing tax disputes.
- Customer and geographic concentration, including the effect of export-control changes on China-related business.
- Capital allocation and leverage: repurchases and dividends, the $275 million revolving-facility borrowing, and debt covenant headroom.